ABSTRACT
SUBMISSION
Key Information
FOR SUBMITTERS
The organizers of the SNO/ASCO Conference on CNS Metastases welcome the submission of original research and clinical findings addressing CNS basic science research, translational research, and clinical trials. Previously presented (encore) or not yet presented clinical trial abstracts and trials in progress are welcome but must be identified as such in the submission process. All submissions are peer-reviewed and accepted abstracts are presented as oral talks or in-person posters. Electronic posters will be available online at the start of the Conference.
CNS Metastases Abstract Submission Categories in 2026:
· Multimodality Approaches
· Radiation Therapy Advances
· Translational Science and Biomarkers
· Basic Science of Leptomeningeal Disease
· Neurocognitive Outcomes, Toxicity, and QOL
· Preclinical Approaches to CNS Metastases
· Research Methods and Trial Design Considerations
· Data Sciences/AI Advances
· Trials in Progress (data can be presented)
· Clinical Trials
· Neuroimaging/Radiologic Advances
· Supportive and Palliative Care
· Surgical Advances and Device Advances
Deadline for submissions is Friday, March 27, 2026, 11:59 pm ET.
Accepted abstracts will be published and indexed in Neuro-Oncology Advances.